Navigation Links
Stem Cell Research Offers Clues About Schizophrenia
Date:9/12/2014

FRIDAY, Sept. 12, 2014 (HealthDay News) -- New research involving stem cells may provide clues about the chemical basis for schizophrenia, scientists report.

Brain cells of people with this chronic and disabling brain disorder give off higher amounts of three neurotransmitters linked to a range of psychiatric disorders, researchers found. Neurotransmitters are chemicals that trigger or block the transmission of electrical signals in the brain.

Although the cause of schizophrenia remains unknown and there is no cure, the study authors suggested their findings shed new light on the chemical basis of the disorder. Ultimately, they believe the study results could help scientists treat patients with schizophrenia more effectively.

"The study provides new insights into neurotransmitter mechanisms in schizophrenia that can lead to new drug targets and [treatments]," study senior author Vivian Hook, a professor with Skaggs School of Pharmacy at the University of California, San Diego, School of Medicine.

"All behavior has a neurochemical basis in the brain. This study shows that it is possible to look at precise chemical changes in neurons of people with schizophrenia," she said in a university news release.

In conducting the study, published online Sept. 11 in Stem Cell Reports, researchers created working brain cells using stem cell technology. The brain cells were activated to secrete neurotransmitters.

The brain cells taken from people with schizophrenia gave off higher amounts of three neurotransmitters: dopamine, norepinephrine and epinephrine.

The researchers also found that for people with schizophrenia, more brain cells were focused on production of tyrosine hydroxylase -- an initial step in the production of dopamine. They noted that both norepinephrine and epinephrine are made from dopamine.

Potentially, the findings could help doctors evaluate the severity of a patient's disease, identify different types of schizophrenia and determine which treatments would be most effective.

"It is very powerful to be able to see differences in neurons derived from individual patients," Hook concluded.

The U.S. National Institutes of Health provided partial funding for the study.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

SOURCE: University of California, San Diego, news release, Sept. 11, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Laparoscopic Devices Market 2014-2018 Global Forecasts and Analysis in New Research Report at ReportsnReports.com
2. World BoPET Market: Biaxially-oriented Polyethylene Terephthalate 2014 Analysis Now Available at DeepResearchReports.com
3. Diabetes researchers find faster way to create insulin-producing cells
4. Sodium Hydroxide Market & Sodium Fluoride Industry (Global, China) Research Analysis Now at DeepResearchReports.com
5. Researchers make scientific history with new cellular connection
6. Dartmouth research links genetic mutation and melanoma progression
7. Nova Southeastern University researcher receives a nearly $2 million grant
8. Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
9. Researchers Probe Molecular Cause for Glaucoma
10. Global Skincare Devices Market Is Expected To Be Worth $12,799.5 Million By 2020: Grand View Research, Inc
11. Even small stressors may be harmful to mens health, new OSU research shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cell Research Offers Clues About Schizophrenia
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology: